Search research articles
Contact Us
Filters
Showing results (291-300 of 297) with videos related to
Page
of 30
Sort By:
You have reached the last page of results.
This site can display upto 297 results.
Lung Cancer (Amsterdam, Netherlands)
|
October 30, 2020
Integrated histological and molecular analyses of rebiopsy samples at osimertinib progression improve post-progression survivals: A single-center retrospective study
Jiang-Tao Cheng, Yi-Hui Yao, Yu-Er Gao, et al.
Iscience
|
July 18, 2024
The efficacy of postoperative radiotherapy in resected pⅢA-N2 EGFR mutant and wild-type lung adenocarcinoma
Yue Zeng, Xing-Xiang Pu, Feng-Jiao He, et al.
The Lancet. Respiratory Medicine
|
March 28, 2025
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
Nan-Shan Zhong, Rong Qiu, Jie Cao, et al.
Translational Lung Cancer Research
|
June 13, 2022
Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trial
Quan Liu, Juan-Ying Xu, Ye-Hong Xu, et al.
Chest
|
July 21, 2022
A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection
Wei-Jie Guan, Jin-Fu Xu, Hong Luo, et al.
Translational Lung Cancer Research
|
November 19, 2020
Pemetrexed-based chemotherapy for non-small-cell lung cancer patients with <i>EGFR</i> exon 20 insertion mutation: a multicenter study
Chun-Wei Xu, Wen-Xian Wang, Dong Wang, et al.
Plos One
|
June 9, 2016
Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data
Guo-Feng Chen, Lai Wei, Jing Chen, et al.
Page
of 30
Search research articles
Search
Showing results (291-300 of 297) with videos related to
Sort By:
Page
of 30
You have reached the last page of results.
This site can display upto 297 results.
Lung Cancer (Amsterdam, Netherlands)
|
October 30, 2020
Integrated histological and molecular analyses of rebiopsy samples at osimertinib progression improve post-progression survivals: A single-center retrospective study
Jiang-Tao Cheng, Yi-Hui Yao, Yu-Er Gao, et al.
Iscience
|
July 18, 2024
The efficacy of postoperative radiotherapy in resected pⅢA-N2 EGFR mutant and wild-type lung adenocarcinoma
Yue Zeng, Xing-Xiang Pu, Feng-Jiao He, et al.
The Lancet. Respiratory Medicine
|
March 28, 2025
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
Nan-Shan Zhong, Rong Qiu, Jie Cao, et al.
Translational Lung Cancer Research
|
June 13, 2022
Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trial
Quan Liu, Juan-Ying Xu, Ye-Hong Xu, et al.
Chest
|
July 21, 2022
A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection
Wei-Jie Guan, Jin-Fu Xu, Hong Luo, et al.
Translational Lung Cancer Research
|
November 19, 2020
Pemetrexed-based chemotherapy for non-small-cell lung cancer patients with <i>EGFR</i> exon 20 insertion mutation: a multicenter study
Chun-Wei Xu, Wen-Xian Wang, Dong Wang, et al.
Plos One
|
June 9, 2016
Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data
Guo-Feng Chen, Lai Wei, Jing Chen, et al.
Page
of 30